TCL1B / TCL1 antibody
Principal name
TCL1B / TCL1 antibody
Alternative names for TCL1B / TCL1 antibody
TCL-1, SYN-1, T-cell leukemia/lymphoma protein 1B, Syncytiotrophoblast-specific protein, TCL1/MTCP1-like protein 1
SwissProt ID
O95988 (Human)
Gene ID
9623 (TCL1B)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection))
Background of TCL1B / TCL1 antibody
- Kit Component:
- - KN208593G1, TCL1B gRNA vector 1 in pCas-Guide vector
- KN208593G2, TCL1B gRNA vector 2 in pCas-Guide vector
- KN208593D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Laine J., et al. (2000) Mol. Cell. 6:395-407 Laine J., et al. (2002) J. Biol. Chem. 277:3743-3751
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN208593 | TCL1B - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN208593BN | TCL1B - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN208593LP | TCL1B - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN208593RB | TCL1B - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP308593 | TCL1B / TCL1 (transcript variant 1) |
||||
| Recombinant protein of human T-cell leukemia/lymphoma 1B (TCL1B), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
| AR51224PU-N | TCL1B / TCL1 (1-128, His-tag) |
||||
 |
Human | Purified | > 95 % by SDS - PAGE | E. coli |
0.5 mg /
€730.00
|
| Acris Antibodies GmbH | |||||
| AR51224PU-S | TCL1B / TCL1 (1-128, His-tag) |
||||
|
Human | Purified | > 95 % by SDS - PAGE | E. coli |
0.1 mg /
€300.00
|
| Acris Antibodies GmbH | |||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC208593L2V | Lenti ORF particles, TCL1B (mGFP-tagged) - Human T-cell leukemia/lymphoma 1B (TCL1B), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC221046L2V | Lenti ORF particles, TCL1B (mGFP-tagged) - Human T-cell leukemia/lymphoma 1B (TCL1B), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC208593L1V | Lenti ORF particles, TCL1B (Myc-DDK tagged) - Human T-cell leukemia/lymphoma 1B (TCL1B), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€804.00
|
|
| OriGene Technologies, Inc. | ||
| RC221046L1V | Lenti ORF particles, TCL1B (Myc-DDK tagged) - Human T-cell leukemia/lymphoma 1B (TCL1B), transcript variant 2 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€804.00
|
|
| OriGene Technologies, Inc. | ||
